A photo of Meilan Rutter.

Medical Director, Differences of Sex Development (DSD) Center

Assistant Director, Pediatric Endocrinology Fellowship Training Program

Associate Professor, UC Department of Pediatrics

513-636-4744

513-636-7486

Board Certified

Best Doctors logo

My Biography & Research

Biography

Meilan Rutter is board-certified in pediatric endocrinology, and has been on the faculty of Cincinnati Children’s Hospital Medical Center and the University of Cincinnati since 2008. She completed her training in the United Kingdom, New Zealand and Cincinnati. She serves as the medical director of the Cincinnati Children’s Differences of Sex Development (DSD) Center and the assistant director of the pediatric endocrinology fellowship training program.

Dr. Rutter cares for children and adolescents with a wide spectrum of endocrine conditions, including growth, puberty, thyroid and adrenal disorders. She collaborates with interdisciplinary specialists to deliver the endocrine aspects of comprehensive and integrated care for patients with complex conditions. She leads the Cincinnati Children’s DSD Center, which provides interdisciplinary care for people born with conditions affecting reproductive development. The DSD Center is a member of the DSD-Translational Research Network, a national network that strives to optimize and standardize clinical practices and advance scientific knowledge in this field. Dr. Rutter also serves as the primary endocrine consultant for the Cincinnati Comprehensive Neuromuscular Center. In conjunction with the neuromuscular team, she has helped pioneer global awareness of the importance of endocrine issues in patients affected by Duchenne Muscular Dystrophy.

Additional Languages

French, Mandarin

Clinical Interests

Pediatric endocrinology, including growth, puberty, thyroid and adrenal disorders; differences of sex development, or conditions affecting reproductive development; endocrine and bone health in neuromuscular conditions

Research Interests

Differences of sex development; endocrine issues and bone health associated with Duchenne muscular dystrophy

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Endocrinology, Fanconi Anemia, Leukemia, Neuromuscular Disorders, Diabetes, 22Q-VCFS, Differences of Sex Development, Sturge-Weber Syndrome

Research Divisions

Endocrinology

My Locations

My Education

MB, BCh: University of Wales College of Medicine, Cardiff, United Kingdom.

FRACP: Royal Australasian College of Physicians, New Zealand.

Residency: University Hospital of Wales, Cardiff, United Kingdom; Auckland Children's Hospital, Auckland, and Dunedin Hospital, Dunedin, New Zealand; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Certification: American Subspecialty Board of Pediatric Endocrinology, 2003, recertified 2013; American Board of Pediatrics, 2002; Fellow of the Royal Australasian College of Physicians (Pediatrics), 1995.

My Publications

Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al. Osteoporosis International. 2020; 31:2449-2459.

XY gonadal dysgenesis in a phenotypic female identified by direct-to-consumer genetic testing. Kim, A; Abell, K; Johnson, J; Cizek, S; Breech, L; Ernst, MM; Hopkin, RJ; Kennedy, K; Stanek, J; Strine, AC; et al. Pediatrics. 2020; 146:e20193302-e20193302.

Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Chernock, RD; Rivera, B; Borrelli, N; Hill, DA; Fahiminiya, S; Shah, T; Chong, A; Aqil, B; Mehrad, M; Giordano, TJ; et al. Modern Pathology. 2020; 33:1264-1274.

Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Rybalsky, I; Shellenbarger, KC; Rutter, MM. Neuromuscular Disorders. 2020; 30:599-610.

Newborn screening protocols and positive predictive value for congenital adrenal hyperplasia vary across the United States. Speiser, PW; Chawla, R; Chen, M; Diaz-Thomas, A; Finlayson, C; Rutter, MM; Sandberg, DE; Shimy, K; Talib, R; Cerise, J; et al. International Journal of Neonatal Screening. 2020; 6:37-37.

Recombinant human insulin-like growth factor-1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy. Rutter, MM; Wong, BL; Collins, JJ; Sawnani, H; Taylor, MD; Horn, PS; Backeljauw, PF. Muscle and Nerve. 2020; 61:623-631.

Loss-of-Function Variants in PPP1R12A: From Isolated Sex Reversal to Holoprosencephaly Spectrum and Urogenital Malformations. Hughes, JJ; Alkhunaizi, E; Kruszka, P; Pyle, LC; Grange, DK; Berger, SI; Payne, KK; Masser-Frye, D; Hu, T; Christie, MR; et al. The American Journal of Human Genetics. 2020; 106:121-128.

Differentiated Thyroid Cancer in the Pediatric/Adolescent Population: Evolution of Treatment. Remiker, AS; Chuang, J; Corathers, S; Rutter, MM; Rutter, MJ; Myer, CM; Gelfand, MJ; Trout, AT; Geller, JI. Journal of Pediatric Hematology/Oncology. 2019; 41:532-536.

Central Diabetes Insipidus in a Patient With NFKB2 Mutation: Expanding the Endocrine Phenotype in DAVID Syndrome. Nasomyont, N; Lindsley, AW; Assa'ad, A; Dawson, DB; Neilson, DE; Brady, CC; Rutter, MM. Journal of Clinical Endocrinology and Metabolism. 2019; 104:4051-4057.

Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naive Patients with Duchenne Muscular Dystrophy. Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al. The Journal of Pediatrics. 2019; 210:194-200.e2.